AU4078300A - Improved dialysis solutions and methods - Google Patents

Improved dialysis solutions and methods

Info

Publication number
AU4078300A
AU4078300A AU40783/00A AU4078300A AU4078300A AU 4078300 A AU4078300 A AU 4078300A AU 40783/00 A AU40783/00 A AU 40783/00A AU 4078300 A AU4078300 A AU 4078300A AU 4078300 A AU4078300 A AU 4078300A
Authority
AU
Australia
Prior art keywords
methods
dialysis solutions
improved dialysis
improved
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40783/00A
Inventor
Billy Hudson
Raja Khalifah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas Medical Center
Original Assignee
University of Kansas Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas Medical Center filed Critical University of Kansas Medical Center
Publication of AU4078300A publication Critical patent/AU4078300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40783/00A 1999-04-06 2000-04-06 Improved dialysis solutions and methods Abandoned AU4078300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12790699P 1999-04-06 1999-04-06
US60127906 1999-04-06
PCT/US2000/009241 WO2000059493A2 (en) 1999-04-06 2000-04-06 Improved dialysis solutions and methods

Publications (1)

Publication Number Publication Date
AU4078300A true AU4078300A (en) 2000-10-23

Family

ID=22432569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40783/00A Abandoned AU4078300A (en) 1999-04-06 2000-04-06 Improved dialysis solutions and methods

Country Status (4)

Country Link
EP (1) EP1165079A2 (en)
AU (1) AU4078300A (en)
CA (1) CA2360311C (en)
WO (1) WO2000059493A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002039994A2 (en) 2000-11-20 2002-05-23 University Of Kansas Medical Center Methods for the treatment and prevention of urinary stone disease
EP1380290A1 (en) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-beta structure pathway and its therapeutic relevance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2078509T3 (en) * 1990-02-19 1995-12-16 Senju Pharma Co MAILLARD REACTION INHIBITING COMPOSITIONS.
US5744451A (en) * 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
KR100478181B1 (en) * 1998-08-24 2005-03-23 토카이 유니버시티 에듀케이셔널시스템 Drugs for relieving carbonyl stress and peritoneal dialysates

Also Published As

Publication number Publication date
CA2360311A1 (en) 2000-10-12
CA2360311C (en) 2003-03-18
WO2000059493A3 (en) 2001-02-01
WO2000059493A2 (en) 2000-10-12
EP1165079A2 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AU3884701A (en) Cardiac methods and system
AU6758800A (en) Pump systems and methods
AU3726700A (en) Methods and devices for preparing hemodialysis solutions
AU7735600A (en) Port blocking method and system
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2001253043A1 (en) Telecommunications system and methods
AU2001275441A1 (en) Filter arrangement and methods
AU2001274525A1 (en) Automatic dialyzer and dialyzing method
AU2955200A (en) Cannula
AU4224900A (en) Carpet and carpet making methods
AU3862600A (en) Multifonctional laminate structure and process
AU715620C (en) Therapeutic methods and uses
AU5878200A (en) External system interface method and system
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU3075200A (en) Telephone and telephone system
AUPP924799A0 (en) Improved separator and process
AU3844299A (en) Improvements in medical guidewires
AU5562100A (en) Irrigation method and system
AU6385600A (en) Interconnect assemblies and methods
AU1083501A (en) Antibiotic-metal complex and methods
AU2001283299A1 (en) Basecalling system and protocol
AU6647200A (en) Flash-spinning process and solution
AU2312500A (en) Cage former and clamp therefor
AU2136401A (en) P450rai-2 and related proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase